Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach (Q37229912)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 April 2009

Language	Label	Description	Also known as
English	Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach	scientific article published on 15 April 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

Cécile Proust-Lima

1

object named as

Cécile Proust-Lima

0 references

author name string

Cécile Proust-Lima

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Jeremy M G Taylor

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

publication date

15 April 2009

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

10

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

535-549

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

maintained by WikiProject

WikiProject Mathematics

0 references

Determinants of change in prostate-specific antigen over time and its association with recurrence after external beam radiation therapy for prostate cancer in five large cohorts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

6 September 2017

Quantifying the predictive performance of prognostic models for censored survival data with time-dependent covariates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

6 September 2017

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

6 September 2017

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

6 September 2017

Partly conditional survival models for longitudinal data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

6 September 2017

Joint modelling of longitudinal measurements and event time data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

6 September 2017

What do we mean by validating a prognostic model?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

6 September 2017

Assessment and comparison of prognostic classification schemes for survival data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

6 September 2017

Random-effects models for longitudinal data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

6 September 2017

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

14 September 2017

Prospective accuracy for longitudinal markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

14 September 2017

Individualized predictions of disease progression following radiation therapy for prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

14 September 2017

Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

28 September 2017

Survival model predictive accuracy and ROC curves

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

3 September 2018

Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

3 September 2018

Identification and efficacy of longitudinal markers for survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

3 September 2018

Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

3 September 2018

Replacing time since human immunodeficiency virus infection by marker values in predicting residual time to acquired immunodeficiency syndrome diagnosis. Multicenter AIDS Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2697347

3 September 2018

An Algorithm for Least-Squares Estimation of Nonlinear Parameters

1 reference

https://api.crossref.org/works/10.1093%2FBIOSTATISTICS%2FKXP009

21 January 2018

Estimating the Dimension of a Model

1 reference

https://api.crossref.org/works/10.1093%2FBIOSTATISTICS%2FKXP009

21 January 2018

Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19369642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive accuracy and explained variation in Cox regression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19369642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19369642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/BIOSTATISTICS/KXP009

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

zbMATH Open document ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37229912&oldid=2203438705"